Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of -25.73% is 72% above its 5-year average of -91.39%, near the high end of its 5-year range (-631.78%–-25.73%).
As of the fiscal period ended Tuesday, June 30, 2026. 28.09% above its 12-month average of -35.78%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q4 FY2026 (2026-06-30): -25.73%.
RETURN ON EQUITY (ROE)
-25.73%
RETURN ON EQUITY (ROE) AVG TTM
-35.78%
RETURN ON EQUITY (ROE) AVG 3Y
-41.47%
RETURN ON EQUITY (ROE) AVG 5Y
-91.39%
RETURN ON EQUITY (ROE) AVG 10Y
-77.09%
RETURN ON EQUITY (ROE) AVG 15Y
N/A
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
+28.09%
CURRENT VS 3Y AVG
+37.96%
CURRENT VS 5Y AVG
+71.85%
CURRENT VS 10Y AVG
+66.63%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-40.09%
median of 647 covered companies
CURRENT VS SECTOR MEDIAN
+35.82%
vs the sector median at left
Benitec Biopharma Inc.
Market Cap
$304.21M
Return on Equity (ROE)
-25.73%
TTM Avg
-35.78%
3Y Avg
-41.47%
5Y Avg
-91.39%
Market Cap
$308.22M
Return on Equity (ROE)
N/A
TTM Avg
30.84%
3Y Avg
30.84%
5Y Avg
30.84%
Market Cap
$296.59M
Return on Equity (ROE)
-135.50%
TTM Avg
-129.54%
3Y Avg
-84.04%
5Y Avg
-77.00%
Market Cap
$319.54M
Return on Equity (ROE)
-41.02%
TTM Avg
-44.84%
3Y Avg
-46.96%
5Y Avg
-38.83%
Market Cap
$288.33M
Return on Equity (ROE)
-18.38%
TTM Avg
-37.53%
3Y Avg
-22.34%
5Y Avg
-10.93%
Market Cap
$288.21M
Return on Equity (ROE)
-49.11%
TTM Avg
-50.02%
3Y Avg
-153.47%
5Y Avg
-149.41%
Market Cap
$287.88M
Return on Equity (ROE)
-56.36%
TTM Avg
-35.98%
3Y Avg
25430.43%
5Y Avg
20391.58%
Market Cap
$321.44M
Return on Equity (ROE)
N/A
TTM Avg
-541.42%
3Y Avg
-296.61%
5Y Avg
-205.57%
Market Cap
$286.75M
Return on Equity (ROE)
-16.18%
TTM Avg
-23.55%
3Y Avg
59.17%
5Y Avg
22.66%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Benitec Biopharma Inc. (BNTC) | $304.21M | -25.73% | -35.78% | -41.47% | -91.39% |
| Mobia Medical, Inc. Common Stock (MOBI)vs › | $308.22M | N/A | 30.84% | 30.84% | 30.84% |
| Larimar Therapeutics, Inc. (LRMR)vs › | $296.59M | -135.50% | -129.54% | -84.04% | -77.00% |
| C4 Therapeutics, Inc. (CCCC)vs › | $319.54M | -41.02% | -44.84% | -46.96% | -38.83% |
| Sagimet Biosciences Inc. (SGMT)vs › | $288.33M | -18.38% | -37.53% | -22.34% | -10.93% |
| Abeona Therapeutics Inc. (ABEO)vs › | $288.21M | -49.11% | -50.02% | -153.47% | -149.41% |
| BridgeBio Oncology Therapeutics Inc. (BBOT)vs › | $287.88M | -56.36% | -35.98% | 25430.43% | 20391.58% |
| Avita Medical Inc. (RCEL)vs › | $321.44M | N/A | -541.42% | -296.61% | -205.57% |
| Standard BioTools Inc. (LAB)vs › | $286.75M | -16.18% | -23.55% | 59.17% | 22.66% |
| Indaptus Therapeutics, Inc. (INDP)vs › | $285.37M | -135.62% | -521.17% | -307.05% | 43.03% |
ROE
-25.7%
ROA
-24.9%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | -25.73% |
| 2026-03-31 | -26.66% |
| 2025-12-31 | -27.46% |
| 2025-09-30 | -52.53% |
| 2025-06-30 | -46.52% |
| 2025-03-31 | -34.67% |
| 2024-12-31 | -31.09% |
| 2024-09-30 | -32.50% |
| 2024-06-30 | -46.04% |
| 2024-03-31 | -188.63% |
| 2023-12-31 | -140.98% |
| 2023-09-30 | -91.55% |
| 2023-03-31 | -423.68% |
| 2022-12-31 | -209.54% |
| 2022-09-30 | -124.93% |
| 2022-06-30 | -631.78% |
| 2022-03-31 | -227.98% |
| 2021-12-31 | -164.06% |
| 2021-09-30 | -104.74% |
| 2021-06-30 | -69.38% |
| 2021-03-31 | -117.24% |
| 2020-12-31 | -75.41% |
| 2020-09-30 | -127.44% |
| 2020-06-30 | -80.98% |
| 2020-03-31 | -54.81% |
| 2019-12-31 | -60.02% |
| 2019-09-30 | -11.84% |
| 2019-06-30 | 21.09% |
| 2019-03-31 | 8.43% |
| 2018-12-31 | 12.78% |
| 2018-09-30 | -14.26% |
| 2018-06-30 | -82.60% |
| 2018-03-31 | -117.69% |
| 2017-12-31 | -79.54% |
| 2017-09-30 | -73.75% |
| 2017-06-30 | -45.86% |
| 2017-03-31 | -53.42% |
| 2016-12-31 | -91.33% |
| 2016-09-30 | -73.14% |
| 2016-06-30 | -167.60% |
| 2016-03-31 | -88.99% |
| 2015-12-31 | -113.83% |
| 2015-09-30 | -78.10% |
| 2015-06-30 | -65.08% |
| 2014-12-31 | -38.46% |
| 2014-09-30 | -27.62% |
| 2014-06-30 | -30.68% |
| 2014-03-31 | -16.35% |
| 2013-12-31 | -48.29% |
| 2013-09-30 | -51.40% |
| 2013-06-30 | -14.24% |
